Hand Osteoarthritis

Patients’ perception of their illness and coping styles may play a role in whether hand osteoarthritis pain improves or deteriorates over the long term, according to data published in Arthritis Care & Research.

New EULAR classification criteria for hand osteoarthritis — including age, morning stiffness duration, radiographic osteophytes and radiographic joint space narrowing — feature separate criteria for thumb base and interphalangeal OA.

Results showed patients with osteoarthritis who underwent carpal tunnel release may use more health care resources and experience more severe and persistent carpal tunnel syndrome symptoms vs. patients without arthritis.

Published results showed use of denosumab may reduce radiographic progression and prevent new erosive joints among patients with erosive hand osteoarthritis.

Morning stiffness lasting longer than 60 minutes is frequent in patients with hand osteoarthritis, and is linked to greater pain, lower function and decreased quality of life, according to data published in Osteoarthritis and Cartilage.

Bone size and trabecular disorganization appear to increase with osteophyte formation and joint space narrowing, while volumetric bone mineral density decreases, according to data published in Arthritis Research & Therapy.

PHILADELPHIA — Denosumab successfully induces structural modifications patients with active erosive hand osteoarthritis, according to data presented at ACR Convergence 2022.

BOSTON — Use of topical analgesics significantly improved pain scores in most patients with symptomatic hand and wrist osteoarthritis; however, according to researchers, the treatment is an undesirable long-term maintenance therapy option.

Patients with hand synovial abnormalities in osteoarthritis demonstrate an abundance of two specific species of gut microbiota, according to findings presented at the 2022 OARSI World Congress.

Global osteoarthritis prevalence increased more than 113% between 1990 and 2019, with the most cases appearing in China, India and the United States, according to data published in Arthritis & Rheumatology.